Winestone, 2019, Disparities in survival and health outcomes in childhood leukemia, Curr Hematol Malig Rep., 14, 179, 10.1007/s11899-019-00515-x
Winestone, 2016, The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia, Am J Hematol., 92, 141, 10.1002/ajh.24605
Gramatges, 2017, Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia, Pediatr Blood Cancer., 64, e26487, 10.1002/pbc.26487
Aplenc, 2006, Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children’s Oncology Group, Blood., 108, 74, 10.1182/blood-2005-10-4004
Li, 2018, Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia, Pediatr Blood Cancer., 66, e27583, 10.1002/pbc.27583
Winestone, 2017, Complications preceding early deaths in Black and White children with acute myeloid leukemia, Pediatr Blood Cancer., 64, e26712, 10.1002/pbc.26712
Fisher, 2010, Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study, Pediatr Blood Cancer., 55, 655, 10.1002/pbc.22601
Winestone, 2019, Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment, Leuk Lymphoma., 60, 2190, 10.1080/10428194.2019.1574002
Gamis, 2014, Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531, J Clin Oncol., 32, 3021, 10.1200/JCO.2014.55.3628
Lange, 2008, Outcomes in CCG-2961, a children’s oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children’s oncology group, Blood., 111, 1044, 10.1182/blood-2007-04-084293
Rubnitz, 2006, Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience, Pediatr Blood Cancer., 48, 10, 10.1002/pbc.20878
Bolouri, 2017, The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions, Nat Med., 24, 103, 10.1038/nm.4439
Health NI of, 2020
Cooper, 2011, AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia., Cancer., 118, 761, 10.1002/cncr.26190
VanderWeele, 2011, Causal mediation analysis with survival data, Epidemiology., 22, 582, 10.1097/EDE.0b013e31821db37e
Lange, 2017, Applied mediation analyses: a review and tutorial, Epidemiol Health., 39, e2017035, 10.4178/epih.e2017035
Therneau, 2020
Team
von Elm, 2008, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, J Clin Epidemiol., 61, 344, 10.1016/j.jclinepi.2007.11.008
Pollard, 2016, CD33 expression and its association with gemtuzumab ozogamicin response: results from the Randomized Phase III Children’s Oncology Group Trial AAML0531, J Clin Oncol., 34, 747, 10.1200/JCO.2015.62.6846
Pui, 2012, Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children’s Research Hospital, 1992 through 2007, J Clin Oncol., 30, 2005, 10.1200/JCO.2011.40.8617
Linabery, 2008, Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999, Cancer., 113, 2575, 10.1002/cncr.23866
Balgobind, 2009, Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study, Blood., 114, 2489, 10.1182/blood-2009-04-215152
Bhatnagar, 2020, Poor survival and differential impact of genetic features of black patients with acute myeloid leukemia, Cancer Discov., 11, 626, 10.1158/2159-8290.CD-20-1579
Winestone, 2018, Increased disease burden among black children compared to white children with newly diagnosed acute myeloid leukemia, Blood., 132, 369, 10.1182/blood-2018-99-120076
Rafiee, 2019, ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial, Blood Cancer J., 9, 51, 10.1038/s41408-019-0211-y
Lamba, 2017, CD33 splicing polymorphism determines gemtuzumab ozogamicin response in de novo acute myeloid leukemia: report from Randomized Phase III Children’s Oncology Group Trial AAML0531, J Clin Oncol., 35, 2674, 10.1200/JCO.2016.71.2513
Galanter, 2012, Development of a panel of genome-wide ancestry informative markers to study admixture throughout the Americas, PLoS Genet., 8, e1002554, 10.1371/journal.pgen.1002554
Scheurer, 2018, An overview of disparities in childhood cancer: report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016, Pediatr Hematol Oncol., 35, 95, 10.1080/08880018.2018.1464088
Ogedegbe, 2020, Responsibility of edical journals in addressing racism in health care, JAMA Netw Open., 3, e2016531, 10.1001/jamanetworkopen.2020.16531
Beck, 2020, The color of health: how racism, segregation, and inequality affect the health and well-being of preterm infants and their families, Pediatr Res., 87, 227, 10.1038/s41390-019-0513-6
Zhang, 2019, Differences in stage of cancer at diagnosis, treatment, and survival by race and ethnicity among leading cancer types, JAMA Netw Open., 3, e202950, 10.1001/jamanetworkopen.2020.2950
